Aardvark Therapeutics AARD
NASDAQ AARD
$4.43 +0.53 (+13.72%)
As of: Oct 21, 2026 · 1:34 PM EDT

Aardvark Therapeutics (AARD) Common Stock Issued (2024 - 2026)

Updated

Analysis

Aardvark Therapeutics (AARD) Common Stock Issued (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,134.17 Bn 1,102.76 Bn 19.71 Bn -
2 Johnson & Johnson 615.84 Bn 534.36 Bn 17.26 Bn 359.00 Mn
3 AbbVie 500.69 Bn 473.80 Bn 12.70 Bn -
4 Merck 367.34 Bn 321.72 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 297.61 Bn 261.60 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.75 Bn 12.86 Bn 6.00 Mn
7 Amgen 235.51 Bn 190.91 Bn 7.24 Bn -
8 Gilead Sciences 190.60 Bn 164.80 Bn 6.22 Bn 9.00 Mn
9 Pfizer 169.37 Bn 116.02 Bn 10.94 Bn -
10 Aardvark Therapeutics 96.89 Mn 22.99 Mn - 262,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 262,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 274,000.00
Sep 30, 2025 171,000.00
Jun 30, 2025 6,000.00
Mar 31, 2025 91.19 Mn
Dec 31, 2024 163,000.00
Sep 30, 2024 169,000.00
API Access

Aardvark Therapeutics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=AARD&period=max&api_key=YOUR_API_KEY